ASCENTAGE
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-26
Analyst
OCRO
Equibles does not estimate personal net worth.
Matthew Biegler is recorded as Analyst at OCRO. Matthew Biegler has spoken on 1 earnings call across 1 company, most recently for ASCENTAGE on March 26, 2026. The companies whose calls Matthew Biegler spoke on are classified in the Healthcare sector.
“Just wanted to piggyback on some earlier comments on the BTK degrader, particularly the ability to combine with LISA in earlier line settings.”
OCRO
Analyst
Transcript header (unverified)
ASCENTAGE
Biotechnology · Healthcare
亚盛医药2025年年度业绩发布会
ASCENTAGE